An Immunological Renal Disease in Transgenic Mice That Overexpress Fli-1 , a Member of the ets Family of Transcription Factor Genes
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The proto-oncogene Fli-1 is a member of the ets family of transcription factor genes. Its high expression in the thymus and spleen and the presence of DNA binding sites for Fli-1 in a number of lymphoid cell-specific gene suggest that Fli-1 is involved in the regulation of lymphopoiesis. Activation of the Fli-1 gene by either chromosomal translocation or viral insertion leads to Ewing's sarcoma in humans and erythroleukemia in mice, respectively. Thus, Fli-1 is normally involved in pathways involved in the regulation of cell growth and differentiation. We have generated H-2Kk-Fli-1 transgenic mice that overexpress Fli-1 in various mouse tissues, with the highest levels of Fli-1 protein in the thymus and spleen. These Fli-1 transgenic mice developed a high incidence of a progressive immunological renal disease and ultimately died of renal failure caused by tubulointerstitial nephritis and immune-complex glomerulonephritis. The incidences of renal disease correlated with the levels of Fli-1 protein in lymphoid tissues of transgenic lines. The hypergammaglobulinemia, splenomegaly, B-cell hyperplasia, accumulation of abnormal CD3+ B220+ T lymphoid cells and CD5+ B220+ B cells in peripheral lymphoid tissues, and detection of various autoantibodies in the sera of diseased Fli-1 transgenic mice suggested the involvement of an immune dysfunction in the pathogenesis of the renal disease. In addition, splenic B cells from transgenic mice exhibited increased proliferation and prolonged survival in vitro in response to mitogens. Taken together, these data suggest that overexpression or ectopic expression of Fli-1 perturbs normal lymphoid cell function and programmed cell death. Thus, H-2Kk-Fli-1 transgenic mice may serve as a murine model for autoimmune disease in humans, such as systemic lupus erythematosus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907 · cited 2×
“The human homolog of Fli-1 is rearranged in Ewing’s sarcoma and neuroepithelioma as a result of a reciprocal chromosomal t(11;22) translocation that fuses the DNA-binding ETS domain of Fli-1 to a novel Nterminal sequence of a gene called EWS derived from chromosome 22 (8).”
BackgroundEllis, L., Clauser, E., Morgan, D. O., Edery, M., Roth, R. A., & Rutter, W. J. (1986) · Cell · doi:10.1016/0092-8674(86)90786-5 · Cited by 1,070 · cited 1×
“enylation site was derived from the vector pECE (9).”
MethodBen-David, Y., Giddens, E. B., Letwin, K., & Bernstein, A. (1991) · Genes & Development · doi:10.1101/gad.5.6.908 · Cited by 403 · cited 4×
“Many members of the ets gene family, including c-ets-1 and -2, Fli-1, erg, Spi-1, and tel, possess oncogenic activity when activated as a result of chromosomal translocations or proviral insertions (3, 8, 12, 35).”
BackgroundInfluentialSelf-citationMacleod, K., Leprince, D., & Stehelin, D. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90404-w · Cited by 304 · cited 3×
“In addition, ets genes are developmentallyregulatedandexpressedinavarietyoftissues, including cells of hematopoietic lineages (13, 19, 27 ).”
BackgroundInfluential
Cited by
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
Origins and Functions of B-1 Cells with Notes on the Role of CD5
Berland, R., & Wortis, H. H. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064833 · Cited by 745
Molecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 688
Ets target genes: past, present and future
Sementchenko, V. I., & Watson, D. K. (2000) · Oncogene · doi:10.1038/sj.onc.1204034 · Cited by 371
“E1 Ets1, GABP ACAGGATATC m, ivf (Granger and Fan, 1998; (murine T-cell) Gunther and Graves, 1994) NIH3T3 Ti-6 Polymerase (HIV-1) U937, CEM PU.1 MS m,e,f (Van Lint et al., 1994) HTLV-1 LTR HeLa SL2 Ets1 MS d (Bosselut et al., 1990; Gegonne et al., 1993; Gitlin et al., 1991) HIV-2 LTR enhancer HL-60, U937, Elf1, PU.1 MS…”
MethodInfluentialHart, A., Melet, F., Grossfeld, P., Chien, K., Jones, C., Tunnacliffe, A., Favier, R., & Bernstein, A. (2000) · Immunity · doi:10.1016/s1074-7613(00)00017-0 · Cited by 369
Self-citationBiology of EWS/ETS fusions in Ewing's family tumors
Arvand, A., & Denny, C. T. (2001) · Oncogene · doi:10.1038/sj.onc.1204598 · Cited by 348
Specificity within the ets Family of Transcription Factors
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60738-1 · Cited by 344
The ETS-domain transcription factor family
Sharrocks, A. D., Brown, A. L., Ling, Y., & Yates, P. R. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00086-1 · Cited by 318
Spyropoulos, D. D., Pharr, P. N., Lavenburg, K. R., Jackers, P., Papas, T. S., Ogawa, M., & Watson, D. K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5643-5652.2000 · Cited by 290
T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy
Sharabi, A., & Tsokos, G. C. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0356-x · Cited by 290
Riggi, N., & Stamenkovic, I. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.009 · Cited by 282
Brown, L. A., Rodaway, A. R. F., Schilling, T. F., Jowett, T., Ingham, P. W., Patient, R. K., & Sharrocks, A. D. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00256-7 · Cited by 260
Expression and function of Ets transcription factors in mammalian development: a regulatory network
Maroulakou, I. G., & Bowe, D. B. (2000) · Oncogene · doi:10.1038/sj.onc.1204039 · Cited by 221
“However, over-expression of this gene in transgenic mice results in B cells that are hyperresponsive to mitogenic stimuli and demonstrate marked reduction in apoptosis and prolonged survival in in vitro culture (Zhang et al., 1995).”
BackgroundCurrent insights into the role of Fli-1 in hematopoiesis and malignant transformation
Ben-David, Y., Gajendran, B., Sample, K. M., & Zacksenhaus, E. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04160-1 · Cited by 54
Dysregulation of granulocyte, erythrocyte, and NK cell lineages in Fli-1 gene–targeted mice
Masuya, M., Moussa, O., Abe, T., Deguchi, T., Higuchi, T., Ebihara, Y., Spyropoulos, D. D., Watson, D. K., & Ogawa, M. (2005) · Blood · doi:10.1182/blood-2003-12-4345 · Cited by 47
Genetic analysis of ETS genes in C. elegans
Hart, A. H., Reventar, R., & Bernstein, A. (2000) · Oncogene · doi:10.1038/sj.onc.1204040 · Cited by 36
Self-citationSuppression of Fli-1 protects against pericyte loss and cognitive deficits in Alzheimer's disease
Li, P., Wu, Y., Hamlett, E. D., Goodwin, A. J., Halushka, P. V., Carroll, S. L., Liu, M., & Fan, H. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.023 · Cited by 33
Metadata
- Authors
- Zhang, L., Eddy, A., Teng, Y.-T., Fritzler, M., Kluppel, M., Melet, F., & Bernstein, A.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1995-12
- Volume
- 15
- Issue
- 12
- Pages
- 6961-6970
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2160254534
- Cited by
- 147
- References
- 4
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.